GXFC3 (Combivir 150 mg / 300 mg)

Generic Name: lamivudine/zidovudine

Pill imprint GXFC3 has been identified as Combivir 150 mg / 300 mg.

Combivir is used in the treatment of occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Combivir 150 mg / 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for GXFC3 (Combivir 150 mg / 300 mg)

Combivir 150 mg / 300 mg GXFC3  Front
Combivir 150 mg / 300 mg GXFC3  Back
Combivir 150 mg / 300 mg GXFC3
Combivir 150 mg / 300 mg GXFC3
Combivir
Generic Name:
lamivudine/zidovudine
Imprint:
GXFC3
Strength:
150 mg / 300 mg
Color:
White
Size:
17.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
GlaxoSmithKline
National Drug Code (NDC):
00173-0595
Inactive Ingredients:
silicon dioxide colloidal
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web4)